-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$70.1424.92% Upside
Crinetics Pharmaceuticals, Inc. Frequently Asked Questions
-
What analysts cover Crinetics Pharmaceuticals, Inc.?
Crinetics Pharmaceuticals, Inc. has been rated by research analysts at H.C. Wainwright, Oppenheimer, Robert W. Baird, Morgan Stanley, Piper Sandler, JMP Securities in the past 90 days.